Cargando…
Alzheimer's Disease: Screening Biomarkers Using Frequency Doubling Technology Visual Field
This study was to investigate the feasibility of frequency doubling technology (FDT) visual field testing in Alzheimer's disease (AD) in order to identify early biomarkers of AD in patients already diagnosed with AD and compare the findings to participants not having Alzheimer's disease. T...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800662/ https://www.ncbi.nlm.nih.gov/pubmed/24187629 http://dx.doi.org/10.1155/2013/989583 |